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The mismatch repair system is one of the mechanisms that safe-
guards the fidelity of genetic information since it corrects replica-
tive errors escaping the DNA polymerase proofreading activity
(Kolodner, 1996; Modrich and Lahue, 1996). Several human DNA
mismatch repair genes have been cloned and involved in heredi-
tary non-polyposis colorectal cancer (HNPCC). These include
hMSH2, homologue of the bacterial gene MutS, which maps on
chromosome 2p21–22, and hMLH1 that maps on chromosome
3p21.3–23 and encodes a homologue of the bacterial MutL and
yeast MLH1 proteins (Fishel et al, 1993; Leach et al, 1993;
Papadopoulos et al, 1994). The inactive forms of mismatch repair
genes might behave as mutator genes causing an accumulation of
spontaneous mutations (especially frameshift) at different genetic
loci, resulting in a mutator phenotype (Aquilina et al, 1994;
Bhattacharyya et al, 1994). This mutator phenotype has been
proposed to account for the multiple mutations required in multi-
stage carcinogenesis (Loeb, 1994). An alteration in the length of
multiple microsatellite loci, which are sequences particularly
prone to slipped-strand mispair because of their repetitive nature,
is typical of the mutator phenotype caused by defects of the
mismatch repair system (Strand et al, 1993; Dunlop, 1996).
Microsatellite instability has been indicated as a replication error
positive (RER+) phenotype, pointing out that replicative errors are
at the basis of this phenomenon. This instability is the hallmark of
colonic and endometrial tumours from HNPCC patients. Several
types of sporadic tumours also show an unstable phenotype: e.g.
10–20% of colonic cancer and 60% of pancreatic cancer (Han et
al, 1993; Kim et al, 1994). Therefore, it is likely that microsatellite
instability is relevant also in the progression of these sporadic
tumours.
Interestingly, the incidence of RER appears to vary in different
sporadic cancers: colorectal tumours and cancers associated with
HNPCC (endometrial and ovary) demonstrate instability at
numerous microsatellite loci; on the other hand, other types of
sporadic tumours (e.g. lung and breast) show fewer and a less
dramatic involvement of microsatellite alterations (Eshleman and
Markowitz, 1995; Honchel et al, 1995). Moreover, a comparative
study concerning the definition of RER+ phenotypes, has divided
sporadic colon tumours into highly unstable (> 20% altered loci)
and lowly unstable (< 10% altered loci) ones and observed that
only in highly unstable tumours is the normal expression of
hMLH1 and hMSH2 lost (Dietmaier et al, 1997).
Current estimates suggest that hMSH2 and hMLH1 mutations
account for the major fraction of the cancers in HNPCC kindreds
(Nystrom-Lahti et al, 1994; Liu et al, 1996). With regard to the
sporadic forms of the same tumours, alterations of these genes
have been shown in only a few cases of colon, endometrial and
ovarian tumours with microsatellite instability (Børresen et al,
1995; Fujita et al, 1995; Katabuchi et al, 1995; Liu et al, 1995;
Moslein et al, 1996; Wu et al, 1997). Methylation of the hMLH1
promoter region has been suggested to be an alternative mecha-
nism of gene inactivation in sporadic colorectal tumours (Kane
et al, 1997). However, the proportion and spectrum of sporadic
tumours associated with inactivation of mismatch repair genes has
not yet been clearly explained.
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Summary Genomic instability has been proposed as a new mechanism of carcinogenesis involved in hereditary non-polyposis colorectal
cancer (HNPCC) and in a large number of sporadic cancers like pancreatic and colon tumours. Mutations in human mismatch repair genes
have been found in HNPCC patients, but their involvement in sporadic cancer has not been clarified yet. In this study we screened
21 pancreatic and 23 colorectal sporadic cancers for microsatellite instability by ten and six different microsatellite markers respectively.
Microsatellite alterations were observed at one or more loci in 66.6% (14/21) of pancreatic cancers and in 26% (6/23) colon tumours, but all
the pancreatic and half of the colon samples showed a low rate of microsatellite instability. All the unstable samples were further analysed for
mutations in the hMLH1 and hMSH2 genes and for hypermethylation of the hMLH1 promoter region. Alterations in the hMLH1 gene were
found only in colorectal tumours with a large presence of microsatellite instability. None of the pancreatic tumours showed any alteration in the
two genes analysed. Our results demonstrate that microsatellite instability is unlikely to play a role in the tumorigenesis of sporadic pancreatic
cancers and confirm the presence of mismatch repair gene alterations only in sporadic colon tumours with a highly unstable phenotype.
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MATERIALS AND METHODS
Tissues and DNA
Samples (21 pancreatic, 23 colon) of resected tumours and corre-
sponding normal tissue (peripheral blood lymphocytes) were
obtained from surgically treated patients at the University of Pisa.
DNA was extracted from frozen tissues according to standard
protocols (Sambrook et al, 1989).
Microsatellite analysis
Ten different microsatellite markers were analysed by polymerase
chain reaction (PCR) amplification. Two markers were localized
on chromosome 2 (D2S313, D2S123); one on chromosome
5 (D5S404); one on chromosome 8 (D8S255); one on chromo-
some 10 (D10S197); one on chromosome 11 (D11S904)
(Weissenbach et al, 1992); and four on chromosome 17q
(D17S250, THRA1, D17S579, D17S396) (Futreal et al, 1992;
Seifert et al, 1996). All microsatellites were dinucleotide (CA)
repeats. The PCR conditions have been described previously
(Futreal et al, 1992; Weissenbach et al, 1992; Seifert et al, 1996).
A 1 ml aliquot of each PCR reaction was diluted threefold with a
buffer consisting of 98% formamide, 20 mM EDTA, 0.05% xilene
cyanol, 0.05% bromophenol blue and loaded, after denaturation,
on a 6% (38:2) polyacrylamide gel containing 8 M urea.
Electrophoresis was conducted at 1400 V for 2–3 h. The gel was
dried on 3 MM Whatman paper and exposed to Kodak XAR film
at –80°C for 6–12 h. In order to confirm the reproducibility of the
experiments, all cases showing microsatellite instability were
examined at least twice by an independently performed PCR and
electrophoresis.
Denaturing gradient gel electrophoresis (DGGE)
Each of 19 exons and exon–intron borders of hMLH1, and each of
16 exons and exon–intron borders of hMSH2 (except for exon 5,
analysed by constant denaturant gradient gel electrophoresis,
CDGE), were screened by DGGE. PCR amplifications of the
DNA extracted from tumour samples (and, in some cases, of the
normal paired DNA) were performed in a 25-ml volume containing
50 ng template, 5 pmol of each primer, 3.75 nmol dNTP and
0.125 unit of Taq polymerase in the buffer provided with different
concentrations of magnesium chloride; in some cases, Triton X-
100 or glycerol was added to enhance the PCR amplification.
Primer sequences and PCR condition have been described previ-
ously (Tannergård et al, 1995; Wahlberg et al, 1997).
Gradient gels were made by mixing 100% denaturant (7 M urea
and 40% formamide) with 0% denaturant stock solution of 7%
acrylamide gels in a gradient maker. Gels were run for 16 h at
85 V, stained with ethidium bromide or silver, and dried on
Whatman 3 MM in a vacuum drier. The gradient gel conditions for
each exon of both genes were described previously (Tannergård et
al, 1995; Wahlberg et al, 1997).
DNA sequencing
DNA sequencing of PCR products of each analysed exon was
performed using cycle sequencing with 33P-labelled ddNTPs and
Thermo Sequenase polymerase (Amersham, Arlington, IL, USA)
according to the manufacturer’s protocol.
hMLH1 promoter methylation assay
This protocol was previously described by Kane et al (1997). A
total of 250 ng of genomic DNA and 0.004 pg of pRDK447 DNA
(a 9.4 kb plasmid containing the yMSH2 gene, a kind gift from
Prof. Kolodner) were digested with HpaII or MspI restriction
endonucleases in a 20-ml volume reaction. pRDK447 DNA served
as internal control for cleavage by HpaII or MspI because it could
be cleaved to completion by these enzymes and because the CpG
sites in the recognition sequences of these enzymes are not cyto-
sine methylated during propagation in Escherichia coli. Reactions
containing either no enzyme, 75 units of HpaII, or 150 units of
MspI were incubated for 6 h at 37°C.
To analyse cleavage of the hMLH1 promoter region, 12.5 ng of
DNA from each digest were analysed by PCR in 25 ml reaction
containing 10 mM Tris-HCL (pH 8.3), 50 mM potassium chloride,
1.5 mM magnesium chloride, 50 mM dNTPs, 0.75 units of
AmpliTaq DNA polymerase, and 2.5 pmol of each primer 27494
(5¢-CGCTCGTAGTATTCGTGC) and 25266 (5¢-TCAGTGC-
CTCGTGCTCAC) designed to amplify nucleotides –670 to –67 of
hMLH1. Importantly for the analysis, HpaII recognition sites were
found at nucleotides positions –567, –527, –347 and –341. PCR
was performed for one cycle of 95°C for 5 min followed by 33
cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 30 s, followed
by one cycle of 72°C for 7 min. The resulting amplification
products were then analysed by agarose gel electrophoresis using
standard methods.
Cleavage of the control DNA was analysed essentially as
described above for the hMLH1 promoter region, with the
following minor modifications. The reactions contained 2.5 pmol
of each primer 27859 (5¢-TTCTTGGAGGACGACAGC) and
27860 (5¢-CAATCACATCTAAATGCG), which amplify a 567-bp
piece of yMSH2 that contains a HpaII site in the middle, in place of
the  hMLH1 primers. In addition, the number of amplification
cycles was increased to 35.
RESULTS
Colon tumours
A total of 23 sporadic colon cancers were analysed for microsatel-
lite alterations using six different markers mapped on six different
chromosomes (2, 5, 8, 10, 11, 17). The presence of microsatellite
alterations (resulting in expansion or contraction of the number of
the repeated units in tumour DNA compared with normal DNA,
Figure 1) was observed in six out of 23 tumours (26%). As shown
in Table 1, only 50% of these samples demonstrated a high
unstable phenotype (more than 40% of altered markers). Tumours
with microsatellite alterations were screened by DGGE for
hMLH1 and  hMSH2 gene mutations. One of the high unstable
colon tumours (sample NG) showed an altered DGGE pattern in
exon 13 of the hMLH1 gene (Figure 2). No alterations were found
in any of the hMSH2 exons. In order to verify whether the alter-
ation was a germline or a somatic change we also analysed the
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detected in the normal DNA, confirming the presence of a somatic
mutation. The PCR product of the tumour sample showing a
DGGE alteration was sequenced in the sense and antisense orien-
tation. The exon 13 alteration in the colon tumour consisted of an
11 bp insertion (TTGTACCCCCC) after the nucleotide 1489 of
the cDNA that caused a premature stop codon TGA after 45
nucleotides (Table 2). This mutation has never been described
before.
Pancreatic tumours
A total of 21 pancreatic sporadic cancers were analysed for
microsatellite alterations using ten different markers mapped on
six different chromosomes (2, 5, 8, 10, 11, 17). The presence of
microsatellite alterations was observed in 14 out of 21 tumours
(66%). As shown in Table 1, all these samples demonstrated a low
unstable phenotype (less than 40% of altered markers). Tumours
with microsatellite alterations were screened by DGGE for
hMLH1 and  hMSH2 gene mutations. Only one pancreatic tumour
showed an altered DGGE pattern in exon 2 of the hMLH1. No
alterations were found in any of hMSH2 exons. In order to verify
whether the alteration was a germline or a somatic change we also
analysed the normal paired DNA. No alterations in the DGGE
pattern could be detected in the normal DNA, confirming the
presence of a somatic mutation. The PCR product of the tumour
sample showing a DGGE alteration was sequenced in the sense
and antisense orientation. The exon 2-altered pattern in the
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Figure 1 Examples of microsatellite instability in colon cancer at locus
D10S197. Arrows point out the alterations in microsatellite repeats: sample
NG shows an expansion in tumour DNA (T) compared with normal DNA (N),
sample OG presents a contraction and an expansion in tumours DNA 1 and
2 (T1 and T2) respectively
MG ME PD PP PG NG* OG1 OG2 PL1
hMLH1 Exon 13
Figure 2 Denaturing gradient gel electrophoresis of exon 13 of hMLH1.
The gel has been silver-stained. Colon sample NG shows aberrant bands
(pointed out by arrows) in tumour DNA compared with tumour DNA extracted
from other patients. The sequence analysis shows that this alteration
consists of an 11 bp insertion (TTGTACCCCCC) after the nucleotide number
1489 that caused a premature stop codon TGA after 45 nucleotides
Table 1 Selected pancreatic and colon tumours showing microsatellite alterations
Microsatellite probes
Unstable Tumour D2S313 D2S123 D5S404 D8S255 D10S197 D11S904 D17S250 THRAI D17S579 D17S396 Total
tumours site
BP Pancreas EXP – – – – – – – – – 1/10
CA Pancreas – – – CONTR – – – – – – 1/10
CI Pancreas – – CONTR ND – – EXP – EXP – 3/9
CR Pancreas – – ND – – – – – – EXP 1/9
FT Pancreas EXP – – – – – – – ND – 1/9
LG Pancreas – – – – – – – – – EXP 1/10
LA Pancreas – – – – – – – – – CONTR 1/10
LF Pancreas – – – – – – – EXP – – 1/10
LD Pancreas ND ND – – – – – EXP ND – 1/7
MG Pancreas – – – – – – – CONTR – – 1/10
ME Pancreas – – – – – – – – – CONTR 1/10
PD Pancreas – – – – – – – – EXP – 1/10
PP Pancreas – EXP – – – – – – – CONTR 2/10
PG Pancreas – ND – – – – ND – EXP CONTR 1/8
NG Colon ND EXP EXP EXP CONTR EXP ND ND ND – 5/6
OG1 Colon ND EXP CONTR EXP CONTR EXP ND ND ND – 5/6
OG2 Colon ND EXP EXP CONTR CONTR – ND ND ND – 4/6
PL1 Colon ND – – – – CONTR ND ND ND – 1/6
PL2 Colon ND – – – – CONTR ND ND ND – 1/6
RA Colon ND – – EXP – – ND ND ND – 1/6
CONTR = contraction in the number of microsatellite repeats; EXP = expansion in the number of microsatellite repeats; – = absence of alterations in the number
of microsatellite repeats; ND = not done; Total = unstable markers on total number analysed.pancreatic tumour resulted in a sequence variant in codon 66
(ACC to ACT) without changes in the coded amino acid (Table 2).
Polymorphism
Two polymorphisms were found in hMLH1. One changed
Ile219®Val (CAT to CGT) in exon 8. The other polymorphism
was in the intron sequence at position 14 of the splice donor site
downstream to exon 13 (G to A). Another two polymorphisms
were found in hMSH2. The first was a G to T switch at position 12
downstream of the 3¢ end of exon 10. The second was a T to G
change located 6-bp upstream from the 5¢ end of exon 13. All these
polymorphisms have been previously described and showed the
same patterns of DGGE of the samples studied in this paper
(Wijnen et al, 1994; Tannergård et al, 1995; Wahlberg et al, 1997).
A comparison was done processing our samples with positive
controls with known polymorphisms; all the samples always
showed the same DGGE patterns.
Methylation of the hMLH1 promoter region
The methylation status of the hMLH1 promoter in pancreatic and
colon samples displaying alterations of microsatellite markers was
examined using a PCR assay. The result of this analysis showed
that only the hMLH1 promoter region from the two high unstable
colon tumours with no alteration in the hMLH1 coding region
(samples OG1 and OG2) was methylated: in both cases the
promoter region was resistant to digestion by HpaII and sensitive
to digestion by MspI (Figure 3 and Table 3). In all the experiments,
the unmethylated internal control DNA was sensitive to digestion
by both enzymes.
DISCUSSION
Fidelity of DNA replication is crucial in avoiding the accumula-
tion of mutations in critical genes and an excessive global muta-
tional load. hMSH2, hMLH1, hPMS1 and hPMS2 are members of
two highly conserved families of post-replication mismatch repair
genes, MutS and MutL (Modrich and Lahue, 1996). Functional
disruption of MutS, MutL, or of their homologues, in bacteria and
yeast increases the rate of spontaneous mutations resulting in a
mutator phenotype (Aquilina et al, 1994; Bhattacharyya et al,
1994; Eshleman et al, 1995). In particular, mutations of these
genes cause a random effect of instability in anonymous sequences
made of di-tri-tetra nucleotide repeats. Microsatellite unstable
cancers were first detected in HNPCC in 1993 (Aaltonen et al,
1993). Since then a large number of studies have demonstrated the
presence of genomic instability in a wide cohort of sporadic and
familial tumours (reviewed by Eshleman and Markowitz, 1995;
Honchel et al, 1995). In this study, 21 pancreatic cancers and 23
colon tumours were analysed to evaluate the incidence of genomic
instability.
Microsatellite instability was found in six out of 23 (26%) colon
tumours, but half of them showed alterations at only one locus out
of six loci analysed. Our findings are in good agreement with
previous studies (Ionov et al, 1993; Kim et al, 1994). The six
RER+ colon tumours were screened for mutations in the hMSH2
and hMLH1 genes. No mutations in the hMSH2 gene, and only one
somatic mutation in the hMLH1 gene, were found. Our results are
in good agreement with previous studies that demonstrated that
14 C Ghimenti et al
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Table 2 hMLH1 alterations found by denaturing gradient gel
electrophoresis
Tumour Exon Nucleotide change Predicted protein
affected change
LA 2 codon 66 None
ACC®ACT
NG 13 11 bp insertion Truncation at
after nucleotide amino acid 511
1489
Table 3 HNPCC genes alterations and microsatellite instability in
pancreatic and colon tumours
Samples Tumour hMLH1 gene hMSH2 gene Number of
site alterations mutations UMM
BP Pancreas No No 1/10
CA Pancreas No No 1/10
CI Pancreas No No 3/9
CR Pancreas No No 1/9
FT Pancreas No No 1/9
LG Pancreas No No 1/10
LA Pancreas No No 1/10
LF Pancreas No No 1/10
LD Pancreas No No 1/7
MG Pancreas No No 1/10
ME Pancreas No No 1/10
PD Pancreas No No 1/10
PP Pancreas No No 2/10
PG Pancreas No No 1/8
NG Colon Mutation in the No 5/6
coding region
OG1 Colon Methylation of the No 5/6
promoter region
OG2 Colon Methylation of the No 4/6
promoter region
PL1 Colon No No 1/6
PL2 Colon No No 1/6
RA Colon No No 1/6
UMM = unstable microsatellite markers.
Figure 3 Analysis of tumour samples for methylation of the hMLH1
promoter region. (A) Amplification of the hMLH1 promoter region from the
indicated tumour DNAs before or after digestion with the indicated restriction
endonucleases. (B) Amplification of unmethylated internal control DNA
before or after digestion with the indicated restriction endonucleases. U,
undigested; M, digested with Msp1; H, digested with HpaII. A DNA weight
marker has been loaded in the first lane on the left
NG
U  M    H
OG1
UM H
OG2
U M H
A
Bmismatch repair gene mutations are very rare in the RER+
sporadic forms of colon cancers: the hMSH2 gene was found to be
altered in only nine out of 62 colon tumours (Børresen et al, 1995;
Liu et al, 1995; Wu et al, 1997); the hMLH1 gene was found to be
mutated in only eight out of 50 colon cancers (Liu et al, 1995;
Moslein et al, 1996, Wu et al, 1997).
Fourteen out of 21 (66.6%) pancreatic tumours were RER+, but
86% (12/14) were altered at a single locus out of the ten analysed;
those samples should probably be classified as stable tumours.
hMLH1 and hMSH2 genes were not found to be altered in any of
those unstable tumours. Pancreatic cancer is a rare disease and
only two studies analysing a limited number of cases have been
published, both reporting an incidence of this phenomenon as low
as the one we found. In the first, two out of six pancreatic tumours
were unstable at only one locus out of the three tested (Han et al,
1993). In the second, one out of five pancreatic tumours was
unstable at one out of the 12 loci tested (Brentnall et al, 1995).
Moreover, this low level of instability is frequently found in other
gastrointestinal cancers such as gastric and oesophageal tumours
(Keller et al, 1995; Muzeau et al, 1997). Our results support the
hypothesis that the genetic mechanism of carcinogenesis in
sporadic pancreatic cancer is not likely to be linked to microsatel-
lite instability.
The low rate of mutations detected in our cohort cannot be
explained by relative low sensitivity of the method because the
DGGE technique is a highly sensitive method and can detect
> 90% of small base sequence alterations, such as splice site, mis-
sense, non-sense and frameshift mutations (Fodde and Losekoot,
1994; Myers et al, 1987). Nevertheless, large deletions and muta-
tions in the region that the primers hybridize may not be detected
by this technique.
Recently,  hMLH1 promoter region methylation has been
proposed as an alternative mechanism by which mismatch repair
genes are silenced (Kane et al, 1997). In our study, we analysed the
methylation status of the hMLH1 promoter region in all the tumour
samples showing alteration of microsatellite markers. Two colon
samples showing a high unstable phenotype and no mutation in the
coding region of the hMLH1 gene displayed resistance to HpaII
digestion, a hallmark for cytosine methylation of CpG islands.
It is therefore interesting to observe that all the colon samples
showing more than 40% of unstable loci show defects in the
mismatch repair gene (mutation in the coding sequence or inacti-
vation by promoter region methylation). These data are in agree-
ment with a comparative study carried out by Dietmaier and
co-workers (1997): colon tumour samples showing less than 20%
of altered markers could not be considered truly unstable and
display a normal expression of hMSH2 and hMLH1.
It has been hypothesized that inactivation of both alleles of the
mismatch repair gene is required to generate an unstable pheno-
type (Leach et al, 1993; Parsons et al, 1993; Liu et al, 1996). We
were unable to demonstrate an altered methylation of the promoter
region of the hMLH1 gene in the colon sample showing only the
somatic mutation of the gene. However, we could not exclude that
the second allele is inactivated by other mechanisms, such as large
deletion or that the found mutation could be dominant-negative
like the truncating mutation at codon 134 of the hPMS2 mismatch
repair gene (Nicolaides et al, 1998).
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